152 related articles for article (PubMed ID: 37812366)
1. High sensitivity flow cytometry immunophenotyping increases the diagnostic yield of malignant pleural effusions.
Subirá D; Barriopedro F; Fernández J; Martínez R; Chara L; Castelao J; García E
Clin Exp Metastasis; 2023 Dec; 40(6):505-515. PubMed ID: 37812366
[TBL] [Abstract][Full Text] [Related]
2. Measurement and immunophenotyping of pleural fluid EpCAM-positive cells and clusters for the management of non-small cell lung cancer patients.
Thompson JC; Fan R; Black T; Yu GH; Savitch SL; Chien A; Yee SS; Sen M; Hwang WT; Katz SI; Feldman M; Vachani A; Carpenter EL
Lung Cancer; 2019 Jan; 127():25-33. PubMed ID: 30642547
[TBL] [Abstract][Full Text] [Related]
3. Detection of EpCAM-positive microparticles in pleural fluid: A new approach to mini-invasively identify patients with malignant pleural effusions.
Roca E; Lacroix R; Judicone C; Laroumagne S; Robert S; Cointe S; Muller A; Kaspi E; Roll P; Brisson AR; Tantucci C; Astoul P; Dignat-George F
Oncotarget; 2016 Jan; 7(3):3357-66. PubMed ID: 26689993
[TBL] [Abstract][Full Text] [Related]
4. CD163+CD14+ macrophages, a potential immune biomarker for malignant pleural effusion.
Wang F; Yang L; Gao Q; Huang L; Wang L; Wang J; Wang S; Zhang B; Zhang Y
Cancer Immunol Immunother; 2015 Aug; 64(8):965-76. PubMed ID: 25944005
[TBL] [Abstract][Full Text] [Related]
5. Flow cytometry immunophenotyping of vitreous specimens does not contribute to diagnosis of lymphoma without supporting morphologic features.
Cantu CA; Green CL; Cummings TJ; Liu B; Dash RC
Diagn Cytopathol; 2019 Apr; 47(4):275-281. PubMed ID: 30485724
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic accuracy of endostatin for malignant pleural effusion: A clinical study and meta-analysis.
Tian P; Shen Y; Feng M; Zhu J; Song H; Wan C; Chen L; Wen F
Postgrad Med; 2015 Jun; 127(5):529-34. PubMed ID: 25979108
[TBL] [Abstract][Full Text] [Related]
7. Pleural fluid cell-free DNA integrity index to identify cytologically negative malignant pleural effusions including mesotheliomas.
Sriram KB; Relan V; Clarke BE; Duhig EE; Windsor MN; Matar KS; Naidoo R; Passmore L; McCaul E; Courtney D; Yang IA; Bowman RV; Fong KM
BMC Cancer; 2012 Sep; 12():428. PubMed ID: 23009708
[TBL] [Abstract][Full Text] [Related]
8. Rapid detection of neoplastic cells in serous cavity effusions in children with flow cytometry immunophenotyping.
Shen H; Tang Y; Xu X; Wang L; Wang Q; Xu W; Song H; Zhao Z; Wang J
Leuk Lymphoma; 2012 Aug; 53(8):1509-14. PubMed ID: 22288605
[TBL] [Abstract][Full Text] [Related]
9. Contribution of flow cytometric immunophenotyping to the evaluation of tissues with suspected lymphoma?
Dunphy CH
Cytometry; 2000 Oct; 42(5):296-306. PubMed ID: 11025488
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic Value of Epithelial Cell Adhesion Molecule Flow Cytometry for Diagnosis of Metastatic Carcinoma in Serous Effusions.
Khodadadi N; Mokhtari M
Acta Cytol; 2023; 67(3):265-272. PubMed ID: 36626892
[TBL] [Abstract][Full Text] [Related]
11. Role of flow cytometry immunophenotyping in the diagnosis of leptomeningeal carcinomatosis.
Subirá D; Serrano C; Castañón S; Gonzalo R; Illán J; Pardo J; Martínez-García M; Millastre E; Aparisi F; Navarro M; Dómine M; Gil-Bazo I; Pérez Segura P; Gil M; Bruna J
Neuro Oncol; 2012 Jan; 14(1):43-52. PubMed ID: 21993441
[TBL] [Abstract][Full Text] [Related]
12. Is neuron-specific enolase useful for diagnosing malignant pleural effusions? evidence from a validation study and meta-analysis.
Zhu J; Feng M; Liang L; Zeng N; Wan C; Yang T; Shen Y; Wen F
BMC Cancer; 2017 Aug; 17(1):590. PubMed ID: 28854885
[TBL] [Abstract][Full Text] [Related]
13. Cell-free DNA methylation analysis as a marker of malignancy in pleural fluid.
Bixby B; Vrba L; Lenka J; Oshiro MM; Watts GS; Hughes T; Erickson H; Chopra M; Knepler JL; Knox KS; Jarnagin L; Alalawi R; Kala M; Bernert R; Routh J; Roe DJ; Garland LL; Futscher BW; Nelson MA
Sci Rep; 2024 Feb; 14(1):2939. PubMed ID: 38316884
[TBL] [Abstract][Full Text] [Related]
14. Precursor T-lymphoblastic lymphoma: Speedy diagnosis in FNA and effusion cytology by morphology, immunochemistry, and flow cytometry.
Bhaker P; Das A; Rajwanshi A; Gautam U; Trehan A; Bansal D; Varma N; Srinivasan R
Cancer Cytopathol; 2015 Sep; 123(9):557-65. PubMed ID: 26243719
[TBL] [Abstract][Full Text] [Related]
15. Pleural Effusion in Multiple Myeloma.
Wang Z; Xia G; Lan L; Liu F; Wang Y; Liu B; Ding Y; Dai L; Zhang Y
Intern Med; 2016; 55(4):339-45. PubMed ID: 26875957
[TBL] [Abstract][Full Text] [Related]
16. [The value of B7-H4 and carcinoembryonic antigen in diagnosing the benign and malignant pleural effusion].
Wei F; Wei Y; Li LF; Li GL; Wang GJ
Zhonghua Zhong Liu Za Zhi; 2017 Jul; 39(7):524-527. PubMed ID: 28728299
[No Abstract] [Full Text] [Related]
17. [Diagnostic value of DNA, RNA and proliferating cell nuclear antigen examination in malignant pleural effusions by flow cytometry].
Wang LX; Chen WX; Wu J; Chen SX; Huang XY; Chen YF
Zhonghua Jie He He Hu Xi Za Zhi; 2006 Dec; 29(12):804-7. PubMed ID: 17327081
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic and prognostic significance of survivin levels in malignant pleural effusion.
Görgün D; Seçik F; Midilli K; Akkaya V; Yıldız P
Respir Med; 2013 Aug; 107(8):1260-5. PubMed ID: 23791464
[TBL] [Abstract][Full Text] [Related]
19. The value of apolipoprotein E in distinguishing benign and malignant unilateral pleural effusions.
Xue Q; Fang G; Deng X; Zhang C; Liu Z; Peng Z; Lai Z; Peng Y; Wu J
Medicine (Baltimore); 2020 Mar; 99(10):e19320. PubMed ID: 32150067
[TBL] [Abstract][Full Text] [Related]
20. Pro-cathepsin D as a diagnostic marker in differentiating malignant from benign pleural effusion: a retrospective cohort study.
Choi H; Ko Y; Lee CY
BMC Cancer; 2020 Aug; 20(1):825. PubMed ID: 32867726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]